ID   MTAP_HUMAN              Reviewed;         283 AA.
AC   Q13126; I2G7M5; I2G7M6; I2G7M7; I2G7M8; I2G7M9; I2G7N0; Q5T3P3;
AC   Q9H010;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   03-APR-2007, sequence version 2.
DT   10-MAY-2017, entry version 178.
DE   RecName: Full=S-methyl-5'-thioadenosine phosphorylase {ECO:0000255|HAMAP-Rule:MF_03155};
DE            EC=2.4.2.28 {ECO:0000255|HAMAP-Rule:MF_03155};
DE   AltName: Full=5'-methylthioadenosine phosphorylase {ECO:0000255|HAMAP-Rule:MF_03155};
DE            Short=MTA phosphorylase {ECO:0000255|HAMAP-Rule:MF_03155};
DE            Short=MTAP {ECO:0000255|HAMAP-Rule:MF_03155};
DE            Short=MTAPase {ECO:0000255|HAMAP-Rule:MF_03155};
GN   Name=MTAP {ECO:0000255|HAMAP-Rule:MF_03155}; Synonyms=MSAP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ILE-56.
RC   TISSUE=Epidermis;
RX   PubMed=7604019; DOI=10.1073/pnas.92.14.6489;
RA   Olopade O.I., Pomykala H.M., Hagos F., Sveen L.W., Espinosa R. III,
RA   Dreyling M.H., Gursky S., Stadler W.M., le Beau M.M., Bohlander S.K.;
RT   "Construction of a 2.8-megabase yeast artificial chromosome contig and
RT   cloning of the human methylthioadenosine phosphorylase gene from the
RT   tumor suppressor region on 9p21.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:6489-6493(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RC   TISSUE=Placenta;
RX   PubMed=8650244; DOI=10.1073/pnas.93.12.6203;
RA   Nobori T., Takabayashi K., Tran P., Orvis L., Batova A., Yu A.L.,
RA   Carson D.A.;
RT   "Genomic cloning of methylthioadenosine phosphorylase: a purine
RT   metabolic enzyme deficient in multiple different cancers.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:6203-6208(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3; 4; 5; 6 AND 7), AND
RP   INVOLVEMENT IN DMSMFH.
RX   PubMed=22464254; DOI=10.1016/j.ajhg.2012.02.024;
RA   Camacho-Vanegas O., Camacho S.C., Till J., Miranda-Lorenzo I.,
RA   Terzo E., Ramirez M.C., Schramm V., Cordovano G., Watts G., Mehta S.,
RA   Kimonis V., Hoch B., Philibert K.D., Raabe C.A., Bishop D.F.,
RA   Glucksman M.J., Martignetti J.A.;
RT   "Primate genome gain and loss: a bone dysplasia, muscular dystrophy,
RT   and bone cancer syndrome resulting from mutated retroviral-derived
RT   MTAP transcripts.";
RL   Am. J. Hum. Genet. 90:614-627(2012).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ILE-56.
RC   TISSUE=Colon;
RA   Li Q., Cao W.-X., Zhang Y., Shi M.-M., Liu B.-Y., Zhu Z.-G.,
RA   Lin Y.-Z.;
RT   "Identification of human methylthioadenosine phosphorylase (MTAP) mRNA
RT   mutation in colon cancer cell line COLO 205.";
RL   Submitted (AUG-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ILE-56.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, AND SUBUNIT.
RX   PubMed=3091600;
RA   Della Ragione F., Carteni-Farina M., Gragnaniello V., Schettino M.I.,
RA   Zappia V.;
RT   "Purification and characterization of 5'-deoxy-5'-methylthioadenosine
RT   phosphorylase from human placenta.";
RL   J. Biol. Chem. 261:12324-12329(1986).
RN   [9]
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND SUBUNIT.
RX   PubMed=8687427; DOI=10.1006/bbrc.1996.0926;
RA   Ragione F.D., Takabayashi K., Mastropietro S., Mercurio C., Oliva A.,
RA   Russo G.L., Pietra V.D., Borriello A., Nobori T., Carson D.A.,
RA   Zappia V.;
RT   "Purification and characterization of recombinant human 5'-
RT   methylthioadenosine phosphorylase: definite identification of coding
RT   cDNA.";
RL   Biochem. Biophys. Res. Commun. 223:514-519(1996).
RN   [10]
RP   INVOLVEMENT IN OSTEOSARCOMA.
RX   PubMed=11895909;
RA   Garcia-Castellano J.M., Villanueva A., Healey J.H., Sowers R.,
RA   Cordon-Cardo C., Huvos A., Bertino J.R., Meyers P., Gorlick R.;
RT   "Methylthioadenosine phosphorylase gene deletions are common in
RT   osteosarcoma.";
RL   Clin. Cancer Res. 8:782-787(2002).
RN   [11]
RP   INVOLVEMENT IN OSTEOSARCOMA.
RX   PubMed=17912432;
RA   Miyazaki S., Nishioka J., Shiraishi T., Matsumine A., Uchida A.,
RA   Nobori T.;
RT   "Methylthioadenosine phosphorylase deficiency in Japanese osteosarcoma
RT   patients.";
RL   Int. J. Oncol. 31:1069-1076(2007).
RN   [12]
RP   INVOLVEMENT IN MALIGNANT MELANOMA.
RX   PubMed=19097084; DOI=10.1002/jcb.21984;
RA   Stevens A.P., Spangler B., Wallner S., Kreutz M., Dettmer K.,
RA   Oefner P.J., Bosserhoff A.K.;
RT   "Direct and tumor microenvironment mediated influences of 5'-deoxy-5'-
RT   (methylthio)adenosine on tumor progression of malignant melanoma.";
RL   J. Cell. Biochem. 106:210-219(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   INVOLVEMENT IN GASTRIC CANCER.
RX   PubMed=21412930; DOI=10.1002/gcc.20867;
RA   Kim J., Kim M.A., Min S.Y., Jee C.D., Lee H.E., Kim W.H.;
RT   "Downregulation of methylthioadenosine phosphorylase by homozygous
RT   deletion in gastric carcinoma.";
RL   Genes Chromosomes Cancer 50:421-433(2011).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) IN COMPLEX WITH MTA.
RX   PubMed=10404592; DOI=10.1016/S0969-2126(99)80084-7;
RA   Appleby T.C., Erion M.D., Ealick S.E.;
RT   "The structure of human 5'-deoxy-5'-methylthioadenosine phosphorylase
RT   at 1.7-A resolution provides insights into substrate binding and
RT   catalysis.";
RL   Structure 7:629-641(1999).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.03 ANGSTROMS) IN COMPLEX WITH SUBSTRATE
RP   ANALOGS.
RX   PubMed=15122881; DOI=10.1021/bi035492h;
RA   Lee J.E., Settembre E.C., Cornell K.A., Riscoe M.K., Sufrin J.R.,
RA   Ealick S.E., Howell P.L.;
RT   "Structural comparison of MTA phosphorylase and MTA/AdoHcy
RT   nucleosidase explains substrate preferences and identifies regions
RT   exploitable for inhibitor design.";
RL   Biochemistry 43:5159-5169(2004).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) IN COMPLEX WITH INHIBITORS.
RX   PubMed=14705926; DOI=10.1021/bi0358420;
RA   Singh V., Shi W., Evans G.B., Tyler P.C., Furneaux R.H., Almo S.C.,
RA   Schramm V.L.;
RT   "Picomolar transition state analogue inhibitors of human 5'-
RT   methylthioadenosine phosphorylase and X-ray structure with MT-
RT   immucillin-A.";
RL   Biochemistry 43:9-18(2004).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 227-237.
RX   PubMed=20934997; DOI=10.3324/haematol.2010.030924;
RA   Bade-Doding C., Theodossis A., Gras S., Kjer-Nielsen L.,
RA   Eiz-Vesper B., Seltsam A., Huyton T., Rossjohn J., McCluskey J.,
RA   Blasczyk R.;
RT   "The impact of human leukocyte antigen (HLA) micropolymorphism on
RT   ligand specificity within the HLA-B*41 allotypic family.";
RL   Haematologica 96:110-118(2011).
CC   -!- FUNCTION: Catalyzes the reversible phosphorylation of S-methyl-5'-
CC       thioadenosine (MTA) to adenine and 5-methylthioribose-1-phosphate.
CC       Involved in the breakdown of MTA, a major by-product of polyamine
CC       biosynthesis. Responsible for the first step in the methionine
CC       salvage pathway after MTA has been generated from S-
CC       adenosylmethionine. Has broad substrate specificity with 6-
CC       aminopurine nucleosides as preferred substrates.
CC       {ECO:0000255|HAMAP-Rule:MF_03155, ECO:0000269|PubMed:3091600}.
CC   -!- CATALYTIC ACTIVITY: S-methyl-5'-thioadenosine + phosphate =
CC       adenine + S-methyl-5-thio-alpha-D-ribose 1-phosphate.
CC       {ECO:0000255|HAMAP-Rule:MF_03155}.
CC   -!- ENZYME REGULATION: Inhibited by 5'-methylthiotubercin and 5'-
CC       chloroformycin.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=5 uM for S-methyl-5'-thioadenosine
CC         {ECO:0000269|PubMed:3091600, ECO:0000269|PubMed:8687427};
CC         KM=580 uM for phosphate {ECO:0000269|PubMed:3091600,
CC         ECO:0000269|PubMed:8687427};
CC         KM=23 uM for adenine {ECO:0000269|PubMed:3091600,
CC         ECO:0000269|PubMed:8687427};
CC         KM=8 uM for S-methyl-5-thio-alpha-D-ribose 1-phosphate
CC         {ECO:0000269|PubMed:3091600, ECO:0000269|PubMed:8687427};
CC       pH dependence:
CC         Optimum pH is 7.2-7.6. {ECO:0000269|PubMed:3091600,
CC         ECO:0000269|PubMed:8687427};
CC   -!- PATHWAY: Amino-acid biosynthesis; L-methionine biosynthesis via
CC       salvage pathway; S-methyl-5-thio-alpha-D-ribose 1-phosphate from
CC       S-methyl-5'-thioadenosine (phosphorylase route): step 1/1.
CC       {ECO:0000255|HAMAP-Rule:MF_03155}.
CC   -!- SUBUNIT: Homotrimer. {ECO:0000255|HAMAP-Rule:MF_03155,
CC       ECO:0000269|PubMed:10404592, ECO:0000269|PubMed:14705926,
CC       ECO:0000269|PubMed:15122881, ECO:0000269|PubMed:3091600,
CC       ECO:0000269|PubMed:8687427}.
CC   -!- INTERACTION:
CC       Q9H3R5:CENPH; NbExp=3; IntAct=EBI-2547776, EBI-1003700;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus {ECO:0000255|HAMAP-
CC       Rule:MF_03155}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=1;
CC         IsoId=Q13126-1; Sequence=Displayed;
CC       Name=2; Synonyms=MTAP_v1;
CC         IsoId=Q13126-2; Sequence=VSP_044074;
CC       Name=3; Synonyms=MTAP_v2;
CC         IsoId=Q13126-3; Sequence=VSP_044075;
CC       Name=4; Synonyms=MTAP_v3;
CC         IsoId=Q13126-4; Sequence=VSP_044076;
CC       Name=5; Synonyms=MTAP_v4;
CC         IsoId=Q13126-5; Sequence=VSP_044071;
CC       Name=6; Synonyms=MTAP_v5;
CC         IsoId=Q13126-6; Sequence=VSP_044072;
CC       Name=7; Synonyms=MTAP_v6;
CC         IsoId=Q13126-7; Sequence=VSP_044073;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC   -!- DISEASE: Diaphyseal medullary stenosis with malignant fibrous
CC       histiocytoma (DMSMFH) [MIM:112250]: An autosomal dominant bone
CC       dysplasia characterized by pathologic fractures due to abnormal
CC       cortical growth and diaphyseal medullary stenosis. The fractures
CC       heal poorly, and there is progressive bowing of the lower
CC       extremities. Some patients show a limb-girdle myopathy, with
CC       muscle weakness and atrophy. Approximately 35% of affected
CC       individuals develop an aggressive form of bone sarcoma consistent
CC       with malignant fibrous histiocytoma or osteosarcoma.
CC       {ECO:0000269|PubMed:22464254}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry. DMSMFH
CC       causing mutations found in MTAP exon 9 result in exon skipping and
CC       dysregulated alternative splicing of all MTAP isoforms
CC       (PubMed:22464254). {ECO:0000269|PubMed:22464254}.
CC   -!- DISEASE: Note=Loss of MTAP activity may play a role in human
CC       cancer. MTAP loss has been reported in a number of cancers,
CC       including osteosarcoma, malignant melanoma and gastric cancer.
CC   -!- SIMILARITY: Belongs to the PNP/MTAP phosphorylase family. MTAP
CC       subfamily. {ECO:0000255|HAMAP-Rule:MF_03155}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U22233; AAA81646.1; -; mRNA.
DR   EMBL; L40432; AAG38871.1; -; mRNA.
DR   EMBL; L42634; AAR24607.2; -; Genomic_DNA.
DR   EMBL; L42627; AAR24607.2; JOINED; Genomic_DNA.
DR   EMBL; L42628; AAR24607.2; JOINED; Genomic_DNA.
DR   EMBL; L42629; AAR24607.2; JOINED; Genomic_DNA.
DR   EMBL; L42630; AAR24607.2; JOINED; Genomic_DNA.
DR   EMBL; L42631; AAR24607.2; JOINED; Genomic_DNA.
DR   EMBL; L42632; AAR24607.2; JOINED; Genomic_DNA.
DR   EMBL; L42633; AAR24607.2; JOINED; Genomic_DNA.
DR   EMBL; HE654772; CCF77345.1; -; mRNA.
DR   EMBL; HE654773; CCF77346.1; -; mRNA.
DR   EMBL; HE654774; CCF77347.1; -; mRNA.
DR   EMBL; HE654775; CCF77348.1; -; mRNA.
DR   EMBL; HE654776; CCF77349.1; -; mRNA.
DR   EMBL; HE654777; CCF77350.1; -; mRNA.
DR   EMBL; AY712791; AAU04442.1; -; mRNA.
DR   EMBL; AL359922; CAI16481.1; -; Genomic_DNA.
DR   EMBL; CH471071; EAW58606.1; -; Genomic_DNA.
DR   EMBL; BC026106; AAH26106.1; -; mRNA.
DR   CCDS; CCDS6509.1; -. [Q13126-1]
DR   PIR; I38969; I38969.
DR   RefSeq; NP_002442.2; NM_002451.3. [Q13126-1]
DR   UniGene; Hs.193268; -.
DR   PDB; 1CB0; X-ray; 1.70 A; A=1-283.
DR   PDB; 1CG6; X-ray; 1.70 A; A=1-283.
DR   PDB; 1K27; X-ray; 1.95 A; A=1-283.
DR   PDB; 1SD1; X-ray; 2.03 A; A=1-283.
DR   PDB; 1SD2; X-ray; 2.10 A; A=1-283.
DR   PDB; 3LN5; X-ray; 1.90 A; C=227-237.
DR   PDB; 3OZC; X-ray; 1.93 A; A=1-283.
DR   PDB; 3OZD; X-ray; 2.10 A; A/B=1-283.
DR   PDB; 3OZE; X-ray; 2.00 A; A/B/C/D/E/F=1-283.
DR   PDB; 5EUB; X-ray; 1.81 A; A=1-283.
DR   PDBsum; 1CB0; -.
DR   PDBsum; 1CG6; -.
DR   PDBsum; 1K27; -.
DR   PDBsum; 1SD1; -.
DR   PDBsum; 1SD2; -.
DR   PDBsum; 3LN5; -.
DR   PDBsum; 3OZC; -.
DR   PDBsum; 3OZD; -.
DR   PDBsum; 3OZE; -.
DR   PDBsum; 5EUB; -.
DR   ProteinModelPortal; Q13126; -.
DR   SMR; Q13126; -.
DR   BioGrid; 110611; 48.
DR   IntAct; Q13126; 12.
DR   MINT; MINT-268764; -.
DR   STRING; 9606.ENSP00000369519; -.
DR   BindingDB; Q13126; -.
DR   ChEMBL; CHEMBL4941; -.
DR   DrugBank; DB02933; 5'-Deoxy-5'-(Methylthio)-Tubercidin.
DR   DrugBank; DB02282; 5'-Deoxy-5'-Methylthioadenosine.
DR   DrugBank; DB00173; Adenine.
DR   DrugBank; DB02281; Formycin.
DR   iPTMnet; Q13126; -.
DR   PhosphoSitePlus; Q13126; -.
DR   BioMuta; MTAP; -.
DR   DMDM; 143811423; -.
DR   REPRODUCTION-2DPAGE; Q13126; -.
DR   UCD-2DPAGE; Q13126; -.
DR   EPD; Q13126; -.
DR   MaxQB; Q13126; -.
DR   PaxDb; Q13126; -.
DR   PeptideAtlas; Q13126; -.
DR   PRIDE; Q13126; -.
DR   DNASU; 4507; -.
DR   Ensembl; ENST00000380172; ENSP00000369519; ENSG00000099810. [Q13126-1]
DR   Ensembl; ENST00000580900; ENSP00000463424; ENSG00000099810. [Q13126-3]
DR   GeneID; 4507; -.
DR   KEGG; hsa:4507; -.
DR   UCSC; uc003zph.4; human. [Q13126-1]
DR   CTD; 4507; -.
DR   DisGeNET; 4507; -.
DR   GeneCards; MTAP; -.
DR   H-InvDB; HIX0007954; -.
DR   H-InvDB; HIX0025895; -.
DR   HGNC; HGNC:7413; MTAP.
DR   HPA; HPA046915; -.
DR   MalaCards; MTAP; -.
DR   MIM; 112250; phenotype.
DR   MIM; 156540; gene.
DR   neXtProt; NX_Q13126; -.
DR   OpenTargets; ENSG00000099810; -.
DR   Orphanet; 85182; Diaphyseal medullary stenosis - bone malignancy.
DR   PharmGKB; PA31220; -.
DR   eggNOG; KOG3985; Eukaryota.
DR   eggNOG; COG0005; LUCA.
DR   GeneTree; ENSGT00550000074874; -.
DR   HOGENOM; HOG000228986; -.
DR   HOVERGEN; HBG002487; -.
DR   KO; K00772; -.
DR   OrthoDB; EOG091G0CQI; -.
DR   PhylomeDB; Q13126; -.
DR   TreeFam; TF312883; -.
DR   BioCyc; MetaCyc:HS01913-MONOMER; -.
DR   BRENDA; 2.4.2.28; 2681.
DR   Reactome; R-HSA-1237112; Methionine salvage pathway.
DR   SABIO-RK; Q13126; -.
DR   SignaLink; Q13126; -.
DR   UniPathway; UPA00904; UER00873.
DR   ChiTaRS; MTAP; human.
DR   EvolutionaryTrace; Q13126; -.
DR   GeneWiki; MTAP; -.
DR   GenomeRNAi; 4507; -.
DR   PRO; PR:Q13126; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000099810; -.
DR   CleanEx; HS_MTAP; -.
DR   ExpressionAtlas; Q13126; baseline and differential.
DR   Genevisible; Q13126; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0004645; F:phosphorylase activity; TAS:ProtInc.
DR   GO; GO:0017061; F:S-methyl-5-thioadenosine phosphorylase activity; TAS:Reactome.
DR   GO; GO:0019509; P:L-methionine salvage from methylthioadenosine; TAS:Reactome.
DR   GO; GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc.
DR   GO; GO:0006166; P:purine ribonucleoside salvage; IEA:UniProtKB-KW.
DR   HAMAP; MF_01963; MTAP; 1.
DR   InterPro; IPR010044; MTAP.
DR   InterPro; IPR000845; Nucleoside_phosphorylase_d.
DR   InterPro; IPR018099; Purine_phosphorylase-2_CS.
DR   PANTHER; PTHR42679; PTHR42679; 1.
DR   Pfam; PF01048; PNP_UDP_1; 1.
DR   SUPFAM; SSF53167; SSF53167; 1.
DR   TIGRFAMs; TIGR01694; MTAP; 1.
DR   PROSITE; PS01240; PNP_MTAP_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Glycosyltransferase; Nucleus; Polymorphism; Purine salvage;
KW   Reference proteome; Transferase.
FT   CHAIN         1    283       S-methyl-5'-thioadenosine phosphorylase.
FT                                /FTId=PRO_0000184545.
FT   REGION       60     61       Phosphate binding.
FT   REGION       93     94       Phosphate binding.
FT   REGION      220    222       Substrate binding.
FT   BINDING      18     18       Phosphate.
FT   BINDING     196    196       Substrate; via amide nitrogen.
FT   BINDING     197    197       Phosphate.
FT   SITE        178    178       Important for substrate specificity.
FT   SITE        233    233       Important for substrate specificity.
FT   MOD_RES      51     51       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9CQ65}.
FT   VAR_SEQ     231    283       VSVDRVLKTLKENANKAKSLLLTTIPQIGSTEWSETLHNLK
FT                                NMAQFSVLLPRH -> MIKFQMILSEGYHPFNIQESPFYRG
FT                                LLDFPSVGHGRGKKCLSAPAIILRPPQPRGTVTTFKVSWSK
FT                                DQTYICMKS (in isoform 5).
FT                                {ECO:0000303|PubMed:22464254}.
FT                                /FTId=VSP_044071.
FT   VAR_SEQ     231    283       VSVDRVLKTLKENANKAKSLLLTTIPQIGSTEWSETLHNLK
FT                                NMAQFSVLLPRH -> MIKFQMILSEGYHPFNIQESPFYRG
FT                                LLDFPSVGHGRGEILPLSPLDLAGYCFQQPMQPPCPDS
FT                                (in isoform 6).
FT                                {ECO:0000303|PubMed:22464254}.
FT                                /FTId=VSP_044072.
FT   VAR_SEQ     232    283       SVDRVLKTLKENANKAKSLLLTTIPQIGSTEWSETLHNLKN
FT                                MAQFSVLLPRH -> RSAFQLPP (in isoform 7).
FT                                {ECO:0000303|PubMed:22464254}.
FT                                /FTId=VSP_044073.
FT   VAR_SEQ     272    283       NMAQFSVLLPRH -> MIKFQMILSEGYHPFNIQESPFYRG
FT                                LLDFPSVGHGRGKKCLSAPAIILRPPQPRGTVTTFKVSWSK
FT                                DQTYICMKS (in isoform 2).
FT                                {ECO:0000303|PubMed:22464254}.
FT                                /FTId=VSP_044074.
FT   VAR_SEQ     272    283       NMAQFSVLLPRH -> MIKFQMILSEGYHPFNIQESPFYRG
FT                                LLDFPSVGHGRGEILPLSPLDLAGYCFQQPMQPPCPDS
FT                                (in isoform 3).
FT                                {ECO:0000303|PubMed:22464254}.
FT                                /FTId=VSP_044075.
FT   VAR_SEQ     272    283       NMAQFSVLLPRH -> VRSAFQLPP (in isoform 4).
FT                                {ECO:0000303|PubMed:22464254}.
FT                                /FTId=VSP_044076.
FT   VARIANT      56     56       V -> I (in dbSNP:rs7023954).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:7604019,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_031470.
FT   CONFLICT    218    218       A -> G (in Ref. 2; AAG38871/AAR24607).
FT                                {ECO:0000305}.
FT   STRAND       11     16       {ECO:0000244|PDB:1CB0}.
FT   HELIX        23     25       {ECO:0000244|PDB:1CB0}.
FT   STRAND       26     32       {ECO:0000244|PDB:1CB0}.
FT   STRAND       45     50       {ECO:0000244|PDB:1CB0}.
FT   STRAND       53     59       {ECO:0000244|PDB:1CB0}.
FT   TURN         60     65       {ECO:0000244|PDB:1CB0}.
FT   HELIX        69     71       {ECO:0000244|PDB:1CB0}.
FT   HELIX        74     83       {ECO:0000244|PDB:1CB0}.
FT   STRAND       87     97       {ECO:0000244|PDB:1CB0}.
FT   STRAND      107    109       {ECO:0000244|PDB:1CG6}.
FT   STRAND      112    116       {ECO:0000244|PDB:1CB0}.
FT   STRAND      126    128       {ECO:0000244|PDB:1CB0}.
FT   STRAND      134    136       {ECO:0000244|PDB:1CB0}.
FT   STRAND      140    142       {ECO:0000244|PDB:3OZE}.
FT   HELIX       146    158       {ECO:0000244|PDB:1CB0}.
FT   STRAND      163    165       {ECO:0000244|PDB:1CB0}.
FT   STRAND      168    172       {ECO:0000244|PDB:1CB0}.
FT   HELIX       180    188       {ECO:0000244|PDB:1CB0}.
FT   STRAND      193    197       {ECO:0000244|PDB:1CB0}.
FT   HELIX       198    207       {ECO:0000244|PDB:1CB0}.
FT   STRAND      211    220       {ECO:0000244|PDB:1CB0}.
FT   TURN        222    224       {ECO:0000244|PDB:3OZC}.
FT   STRAND      225    228       {ECO:0000244|PDB:5EUB}.
FT   HELIX       233    258       {ECO:0000244|PDB:1CB0}.
FT   HELIX       264    275       {ECO:0000244|PDB:1CB0}.
SQ   SEQUENCE   283 AA;  31236 MW;  3B34C565EB5B99DA CRC64;
     MASGTTTTAV KIGIIGGTGL DDPEILEGRT EKYVDTPFGK PSDALILGKI KNVDCVLLAR
     HGRQHTIMPS KVNYQANIWA LKEEGCTHVI VTTACGSLRE EIQPGDIVII DQFIDRTTMR
     PQSFYDGSHS CARGVCHIPM AEPFCPKTRE VLIETAKKLG LRCHSKGTMV TIEGPRFSSR
     AESFMFRTWG ADVINMTTVP EVVLAKEAGI CYASIAMATD YDCWKEHEEA VSVDRVLKTL
     KENANKAKSL LLTTIPQIGS TEWSETLHNL KNMAQFSVLL PRH
//
